Bibliographic information
Recommendation
Women living with severe or advanced HIV clinical disease (WHO stage 3 or 4) can use the following hormonal contraceptive methods without restriction: combined oral contraceptive (pill) (COCs), combined injectable contraceptives (CICs), combined contraceptive patches and rings, progestogen-only pill(POPs), progestogen-only injectable(POIs) (depot medroxyprogesterone acetate and norethisterone enanthate), and levonorgestrel (LNG) and etonogestrel(ETG) implants
Certainty of evidence
Moderate
Notes and Remarks
Because there may be drug interactions between hormonal contraceptives and antiretroviral therapy (ART), refer to the last section of this (the guideline) table, on drug interactions
Also Featured In
This recommendation also appears in the following guidelines:
Medical eligibility criteria for contraceptive use